Silicon Motion Technology Corporation (SIMO)

Regulus Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts that cover Regulus Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $81.67, which forecasts a 9.62% increase in the stock price over the next year. The lowest target is $60 and the highest is $95.

Price Target: $81.67 (+9.62%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$60	$81.67	$90	$95
Change	-19.46%	+9.62%	+20.81%	+27.52%

Analyst Ratings

The average analyst rating for Regulus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	4	4	4	4	5	5
Buy	4	3	3	3	3	3
Hold	0	0	0	0	0	0
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	9	8	8	8	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mehdi Hosseini Susquehanna	Susquehanna	Buy Maintains $90 → $95	Buy	Maintains	$90 → $95	+27.52%	Aug 1, 2025
Nick Doyle Needham	Needham	Strong Buy Maintains $65 → $90	Strong Buy	Maintains	$65 → $90	+20.81%	Jul 31, 2025
Mehdi Hosseini Susquehanna	Susquehanna	Buy Maintains $80 → $90	Buy	Maintains	$80 → $90	+20.81%	Jul 23, 2025
Suji Desilva Roth Capital	Roth Capital	Strong Buy Maintains $70 → $90	Strong Buy	Maintains	$70 → $90	+20.81%	Jun 17, 2025
Craig Ellis B. Riley Securities	B. Riley Securities	Strong Buy Reiterates $75 → $90	Strong Buy	Reiterates	$75 → $90	+20.81%	Jun 5, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

822.12M

Increased by 2.31%

from 803.55M

Revenue Next Year

935.63M

Increased by 13.81%

from 822.12M

EPS This Year

3.53

Increased by 33.57%

from 2.64

EPS Next Year

4.73

Increased by 34.08%

from 3.53

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	539.52M	922.10M	945.92M	639.14M	803.55M	822.12M	935.63M	986.59M
Revenue Growth	17.99%	70.91%	2.58%	-32.43%	25.72%	2.31%	13.81%	5.45%
EPS	2.28	5.72	5.16	1.59	2.64	3.53	4.73	5.22
EPS Growth	24.54%	150.88%	-9.79%	-69.28%	66.54%	33.57%	34.08%	10.35%
Forward PE	-	-	-	-	-	21.13	15.76	14.28
No. Analysts	-	-	-	-	-	11	11	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	884.2M	988.5M	1.1B
Avg	822.1M	935.6M	986.6M
Low	759.6M	833.7M	913.2M

Revenue Growth

Revenue Growth	2025	2026	2027
High	10.0%	20.2%	12.5%
Avg	2.3%	13.8%	5.4%
Low	-5.5%	1.4%	-2.4%

EPS Forecast

EPS	2025	2026	2027
High	3.94	5.62	5.65
Avg	3.53	4.73	5.22
Low	3.19	3.97	4.75

EPS Growth

EPS Growth	2025	2026	2027
High	49.1%	59.3%	19.5%
Avg	33.6%	34.1%	10.4%
Low	20.6%	12.6%	0.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.